Brief: Denali Therapeutics Inc To Discontinue Active Treatment Extension In Regimen G
05/03/2025 23:05
March 5 (Reuters) - Denali Therapeutics Inc DNLI.O: DENALI THERAPEUTICS INC - TO DISCONTINUE ACTIVE TREATMENT EXTENSION IN REGIMEN G Further company coverage: DNLI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Denali Therapeutics
See all newsDenali Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Denali Therapeutics Q2 net loss widens as AVLAYAH launch costs rise
Biogen's Alzheimer's drug lowers toxic protein, but results were mixed
U.S. STOCKS ON THE MOVE-Sweetgreen, Dell Technologies, Peloton Interactive
U.S. STOCKS ON THE MOVE-IMAX, Novo Nordisk, PC makers